Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Obstet Gynecol. 2010 Aug;116(2 Pt 1):284-92. doi: 10.1097/AOG.0b013e3181e8fb60.

    Improving urinary incontinence in overweight and obese women through modest weight loss.

    Source

    Miriam Hospital, Providence, Rhode Island 02903, USA.

    Abstract

    OBJECTIVE:

    To examine the relationship between magnitude of weight loss and changes in urinary incontinence frequency.

    METHODS:

    Overweight and obese women (N=338) with 10 or more urinary incontinence episodes per week were assigned randomly to an intensive 6-month behavioral weight loss program followed immediately by a 12-month weight maintenance program (intervention; n=226) or to a structured education program (control; n=112). The intervention and control groups were combined to examine the effects of the magnitude of weight loss on changes in urinary incontinence assessed by 7-day voiding diary, pad test, and self-reported satisfaction with change in urinary incontinence.

    RESULTS:

    Compared with participants who gained weight (reference), those who lost 5% to less than 10% or 10% or more of their body weight had significantly greater percent reductions in urinary incontinence episodes and were more likely to achieve at least a 70% reduction in the frequency of total and urge urinary incontinence episodes at 6, 12, and 18 months. Satisfaction was also related to magnitude of weight loss; approximately 75% of women who lost 5% to less than 10% of their body weight reported being moderately or very satisfied with their changes in urine leakage.

    CONCLUSION:

    Weight losses between 5% and 10% of body weight were sufficient for significant urinary incontinence benefits. Thus, weight loss should be considered as initial treatment for incontinence in overweight and obese women.

    CLINICAL TRIAL REGISTRATION:

    ClinicalTrials.gov, www.clinicaltrials.gov, NCT00091988.

    LEVEL OF EVIDENCE:

    II.

    PMID:
    20664387
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3038422
    Free PMC Article

    Images from this publication.See all images (1)Free text

    Fig. 1

      Supplemental Content

      Icon for Lippincott Williams & Wilkins Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk